Helping people in Malawi who move around stay on HIV treatment
Tests a support package for people with HIV in Malawi who move often.
Plain-language title generated from the registry record
Registry title: Reducing Mobility-associated Interruption in HIV Treatment in Malawi
Key facts
- Where
- Lilongwe, MalawiSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people living with HIV in Malawi who are starting HIV treatment (ART) for the first time or coming back to it after a break.
- Age
- 15 years or older
- Sex
- All sexes can join.
- Disease stage
- People living with HIV who are starting ART for the first time, or returning to care after missing a refill appointment by more than 28 days.
- Earlier treatment
- Either no earlier ART (starting for the first time, by self-report), or a treatment break after missing a refill by more than 28 days.
Main reasons for not taking part
- Attending the ART clinic on behalf of someone else, such as a guardian
- Attending the ART clinic only to get an emergency refill
- Attending for a routine refill without a recent treatment break of 28 days or more
- Transferring in to the study clinic without a treatment break of 28 days or more
Read by machine on 9 November 2026.
Where in Malawi
- Partners in HopeLilongwe, MalawiTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of California, Los Angeles
- Trial code
- NCT07329166
- Record updated
- 9 January 2026
- Original description
The goal of this pilot clinical trial is to assess the feasibility and acceptability of an intervention package designed to reduce mobility-associated interruptions in HIV treatment in people living with HIV in Malawi who are initiating or returning to antiretroviral treatment (ART) after interruption. The main questions it aims to answer are:Read full original descriptionShow less
Reducing Mobility-associated Interruption in HIV Treatment in Malawi (REMIT): Pilot Trial to Assess Acceptability and Feasibility of a Mobility-specific Intervention Package
The goal of this pilot clinical trial is to assess the feasibility and acceptability of an intervention package designed to reduce mobility-associated interruptions in HIV treatment in people living with HIV in Malawi who are initiating or returning to antiretroviral treatment (ART) after interruption. The main questions it aims to answer are:
* Is the intervention acceptable to healthcare workers and ART clients? * Is the intervention feasible in the context of Malawi's health system, and what are the major operational challenges, resource requirements, and implementation barriers?
In addition, researchers will compare HIV treatment outcomes (specifically ART retention rates) between intervention and control groups to establish a preliminary estimate of the intervention's efficacy.
Participants will complete a survey on the day of enrollment and some participants will complete an in-depth interview and/or a survey after completion of the 6-month follow-up period. Facilities assigned to the intervention group will receive the full package of interventions (training on mobility-specific counseling for counsellors, access to a toll-free hotline for clients and healthcare workers, and training on multi-month dispensing for providers), while facilities assigned to the control group will provide standard of care.
Inclusion: 15 years of age or older; Living with HIV; Attending ART clinic to initiate OR re-initiate care:; Initiate: initiating ART for the first time, per self-report; Re-initiate: returning to care after missing a refill appointment by >28 days.
Exclusion: Attending ART clinic on behalf of someone else (i.e. guardian); Attending ART clinic only to obtain emergency refill; Attending ART clinic for a routine refill without a recent >=28 days interruption in treatment; Transferring in to study facility without a preceding interruption in treatment of >=28 days.